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ABSTRACT
Background: Patients with diabetes mellitus are at a higher risk of lower extremity 
complications as compared to their non-diabetic counterparts. 
Objective: To study risk factors for diabetic foot ulcer disease and stratify patients 
with diabetes into risk categories for foot ulceration. 
Design: Cross-sectional descriptive study over five months period. 
Setting: Diabetic outpatient clinic, at the Kenyatta National Hospital. 
Subjects: Two hundred and eighteen ambulatory subjects with diabetes mellitus 
without active foot lesions. 
Results: The prevalence of previous foot ulceration was 16% while that of previous 
amputation was 8%. Neuropathy was present in 42% of the study subjects and was 
significantly associated with age, male gender, duration of diabetes, random blood sugar, 
systolic blood pressure and the presence of foot deformity. Peripheral arterial disease was 
present in 12% and showed significant association with male gender. Foot deformities 
were observed in 46% of study subjects and were significantly associated with age, male 
gender, and presence of neuropathy. Subsequently 57% were categorised into IWGDF 
group 0 - no neuropathy, 10% were placed in group 1- neuropathy alone, 16% were put 
in group 2 - neuropathy plus either peripheral arterial disease or foot deformity and 
17% were placed in risk group 3 - previous foot ulceration/amputation. 
Conclusion: More than one third (33%) of diabetic patients were found to be at high 
risk for future foot ulceration (lWGDF groups 2 and 3). Published evidence exists 
that shows improved outcomes with interventions targeting individual patients with 
diabetes at high-risk of foot ulceration. Long term prospective studies to determine 
outcomes for the different risk categories should be carried out locally. 
INTRODUCTION
By the year 2010 it is estimated that 221 million 
people will be affected with diabetes globally (1). 
It is thought that the life time risk of developing 
a foot ulcer in a diabetic patient (type 1 or 2) is 
approximately 15% (2). 
 Diabetic foot ulcers are responsible for frequent 
and prolonged admission periods (3). Epidemiological 
studies suggest that foot ulcers precede about 85% 
of non-traumatic lower extremity amputations in 
individuals with diabetes (4). The five year mortality 
following amputation has been found to be between 
39%-68% in various studies (5-7). In a 1999 study, 
the prevalence of diabetic foot ulcers at Kenyatta 
National Hospital was 46 per 1000 diabetic patients, 
with foot ulcers accounting for 12% of all diabetic 
admissions. The morbidity attributable to diabetic foot 
ulcer disease was underscored by the finding that the 
mean ulcer duration was 17 weeks and that 50% of 
patients presented with Wagner stage 2 ulcers whilst 
25% had advanced Wagner stage 4 ulcers (8). 
 Diabetic foot ulcers are a cause of potentially 
preventable morbidity, tragic sequelae, notably lower 
extremity amputation with its grave socio-economic 
consequences, and mortality. 
 Several reports indicate that adequate foot 
examinations are often not performed in diabetic 
patients (9-l0). A lack of clear understanding of the 
most important criteria to include in a screening 
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examination may be contributory (11). Furthermore, 
with the increasing number of patients with diabetes, 
it is difficult to provide in-depth preventive foot 
services for every patient with the disease owing to 
constraints in resources (12,13). 
 Allocation of appropriate intervention modalities 
in high risk diabetic patients has been shown to 
decrease the rate of re-ulceration by up to 60% and 
lower extremity amputation by up to 85% (13). 
 Risk stratification allows prioritisation of 
resources to high risk populations where they will 
have the greatest impact. 
MATERIALS AND METHODS
For each patient, the demographic history was taken 
and the patient’s clinic record consulted. A simple 
questionnaire was then administered to collect 
data concerning previous ulceration, amputation, 
peripheral vascular disease, neurological deficit, and 
foot care knowledge. Height was measured against a 
vertical scale to the nearest half centimetre, with the 
patient standing erect and without shoes. Weight was 
measured to the nearest half kilogram with the patient 
in light clothing, without shoes and using a standard 
weighing chair in the clinic. BMI was calculated as 
the weight in kilograms divided by the square of the 
height in metres and the degree of obesity classified 
as follows (14). 
BMI (kg/m2) Degree of obesity 
<25  Non obese
25-29.9 Overweight 
30-39.9 Obese 
>40  Very obese 
Blood pressure was measured with the patient in 
the supine position after a rest period of 5 minutes, 
using standard procedure. Hypertension was defined 
as follows: 
Category Systolic BP  Diastolic BP
 (mmHg)  (mmHg) 
Optimal  <120 <80 
Normal  <130 <85 
High normal  130-139 85-89 
Hypertension  
   Stage 1  140-159 90-99
   Stage 2 160-179 100-109
   Stage 3  >180 > 110 
   Isolated systolic 
   hypertension  > 140  <90 
The feet were then examined: 
Inspection: The patient was observed while walking 
from one end of the examination room to the other 
and any abnormality of gait due to pain or deformity 
recorded. With the patient standing, the feet and 
the ankles were inspected for hind foot deformities 
(valgus/varus), pes planus, pes cavus, toe deformities 
(hallux valgus, claw toe, mallet toe, hammer toe) and 
prominent metatarsal heads. With the patient supine, 
the condition of the nails and skin was noted as was 
the presence of swellings. The presence of callosities 
was recorded. The presence of high risk lesions such 
as fungal infections was also recorded. 
Palpation:The hind-foot, mid-foot and fore-foot 
were palpated to accurately localise any tenderness, 
swelling or deformity. The passive range of movement 
of the ankle joint, sub-talar and mid-tarsal joints 
was then assessed and each recorded as normal, 
or restricted. The individual toes were assessed to 
identify any restriction of movement, and this was 
recorded as normal or restricted. The posterior tibial 
pulse and the dorsalis pedis were then assessed and 
graded as normal, reduced or absent. The presence 
of blanching on elevation, rubor on dependance and 
delayed capillary refill was then assessed. 
Neurological exam: For each foot the Achilles tendon 
reflex was tested using a standard patella hammer 
and a standard technique. The score below was 
assigned: 
 Absent (2 points for each foot) 
 Present with reinforcement (1 point for each 
foot) 
 Present without reinforcement (0 points) 
Vibration sense was tested using a 128HZ tuning 
fork over the lateral and medial maleoli and the 
perception graded as: 
 Normal (0 points) 
 Absent or reduced (1 point for each foot) 
Pressure sensation was then tested using a 5.07 (10-g) 
monofilament. This was done at six points on the foot 
and recorded as normal or abnormal. 
 Pinprick sensation was assessed on the feet using 
a disposable pin and graded as: 
 Normal - (0 points) 
 Absent or reduced - (1 point for each foot) 
Temperature sensation was assessed using a cold 
tuning fork after immersion in cold water, on the 
dorsum of the feet and the sensation graded as: 
 Normal - 0 points 
 Reduced (1 point for each foot) 
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The neurological disability score was then determined 
and scored as: 
 0 to 2 - no neuropathy 
 3 to 5 - mild neuropathy 
 6 to 8 - moderate 
 9 to 10 – severe.
The score was doubled in patients with previous 
unilateral foot amputation. 
Ankle Brachial Index (ABI) determination: A hand held 
Doppler probe (8 MHz) was held over the three pedal 
arteries (posterior tibial, dorsalis pedis, perforating 
peroneal) in turns while a blood pressure cuff wrapped 
around the ankle was inflated. The pressure at which 
the Doppler signal disappears was recorded as the 
systolic pressure in the artery as it passed under the 
cuff. The ratio of the highest pedal pressure to the 
highest brachial artery pressure determined by the 
Doppler method was recorded as the Ankle Brachial 
Pressure Index and interpreted as follows: 
 > 1.30  Non compressible vessel 
 0.91 - 1.30 Normal 
 0.41 - 0.90 Mild-moderate peripheral arterial 
disease 
 0.00 - 0.40 Severe peripheral arterial disease 
A random blood sugar (RBS) level was then 
determined by aseptic pin prick using a standard 
glucometer. 
Risk stratification: Patients were then placed into one 
of the following IWGDF risk categories: 
Group Category 
0  No neuropathy 
1  Neuropathy present 
  Deformity absent 
  PAD absent 
2  Neuropathy present, plus either 
  deformity or PAD or both 
3  Previous ulcer 
  Previous amputation 
Statistical analysis: Data was collected into a specially 
designed pro-forma and coded before input into 
a statistical computer package (SPSS version 12). 
Descriptive statistics were applied to continuous and 
categorical data from which measures of central tendency 
and proportions were derived. Inferential statistics were 
applied to determine associations between age, gender, 
blood sugar, measures of obesity and neuropathy / 
peripheral arterial disease/ foot deformity. Where 
comparisons were made a p - value of less than 0.05 
was taken to be statistically significant. 
RESULTS
A total of 218 ambulatory patients with diabetes 
mellitus were enrolled into the study. The baseline 
characteristics of the study participants are 
summarised in Table 1. 
Table 1
Baseline characteristics by foot complication
Characteristic  Foot complication  No foot 
 (ulcer and/or  complication 
 amputation)  
Number, n,  174  44 
Age, years (mean ± SD)  58.5+8.9  55.9+9.8 
Male %  39  55 
Duration of diabetes (years)  16.1±4.1  13.8±5.4 
(mean ± SD)   
RBS (mmol/l) (mean ± SD)  11.7+3.9  10+3.4 
BMI (kg/m2)(mean ± SD)  26.2+2.8  24+3.7 
ABl  1.0+0.1  1.1 +0.3 
NDS  2.6+2.6  1.32+0.8 
Deformity (%)  36  82 
SBP (mmHg) (mean ± SD)  135+20  144+12 
Current smoking (%)  1.1  2.3 
Data presented as mean (SD); NDS = Neurological Disability Score; ABI = Ankle Brachial Index 
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The distribution of key variables in the different groups is represented in Table 2
Table 2
Patient characteristics in the different key ulceration risk categories
Characteristic            Neuropathy             Peripheral arterial          Deformity 
                  disease 
 Present  Absent  Present  Absent  Present  Absent 
Number, n,  92  126  26  192  98  120 
Age (years)  62.4±8.5*  56±8.7  58.7±10  57.6±8.9  59.6±10*  56.7±7.8 
(mean±SD)   
Male %  58  33  33*  38  42  43 
Duration of diabetes  18.0±4.4*  14.6±4.2  16.4±3.8  15.5±4.6  15.7±5  15.6±4 
(yrs) (mean ± SD)   
RBS(mmol/1)  12.9±4.3*  10.6±3.5  12.8±3.3  11.l±3.8  11.l±4.3  11.5±3.5 
(mean±sd)   
BMI(kg/m2)(mean±SD)  26.3±3.4  25.6±3  27.2±2.6  25.6±3.2  25.5±3.2  26.1±2.7 
  
ABI  0.99±0.16  1.03±0.13  0.8±0.06  1.03±0.12  1.02±0.16  1.01±0.l3 
NDS    4.5+3  2.0+2.2  2.3+1.9*  2.3+2.2 
Deformity (%)  54*  41  35  46   
SBP(mmHg)  143±16*  134±19  139±21  137±19  141±17  134±19 
 
Data presented as mean (SD); NDS = Neurological Disability Score; ABI = Ankle Brachial Index. *significant 
correlations p<0.05





IWGDF group  Percentage of study subjects in each group
   
0 No neuropathy  57 
1 Neuropathy alone  10 
2 Neuropathy + PAD or deformity  16 
 3   Previous ulcer/ amputation  17 
DISCUSSION
The prevalence of neuropathy in this study was 42% 
(92/218). Neuropathy was assessed through the 
use of the Neurological Disability Score. Using the 
same tool, Mwendwa et al (14) found a prevalence of 
peripheral neuropathy of 28% among patients with 
short-term type 2 diabetes (<2 years) at Kenyatta 
National Hospital. However the mean duration of 
diabetes in their study group was 10.3 months in 
comparison to 15.9 years in this study. The mean age 
of the study population in the study of Mwendwa 
et al (14) was 53.7 years old as compared with the 
older age group in the present study with mean of 
58 years old. Also the current study had more males 
i.e. (42%) versus (37%) in Mwendwa et al (14). Male 
gender has been shown to be strongly associated 
with neuropathy. Thus, the older age group, larger 
number of males, coupled with the increased duration 
of diabetes could have contributed to the higher 
prevalence of neuropathy in this particular study. The 
prevalence of neuropathy has been shown to vary 
widely among countries. Inter-observer variations 
have also occurred within similar populations. A 
comparative study of diabetic patients with foot 
lesions in Germany, India and Tanzania found that 
around 80% in each centre had peripheral neuropathy, 
but only 12 to 13% had evident peripheral arterial 
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disease in Tanzania and India respectively, compared 
to 48% in Germany (15). The basal characteristics of 
the populations of study may vary amongst study 
subjects but evidence suggests that foot lesions in 
developing countries are largely neuropathic in origin. 
Wikbald et at (16) in Tanzania found a prevalence of 
neuropathy in their patients of 28.1%, PVD 12.50%, 
while Elbagir et al (17) in Sudan found peripheral 
neuropathy of 37%, PVD-10%. Other studies have 
documented prevalence of peripheral neuropathy 
including, 27.8% in the San Louis Diabetic Study 
(18) 28% in EURODIAB (19), 60% in a Turkish study 
(20), and 66% in the Rochester Study (21). A recent 
study reported from the middle-east found a high 
prevalence of 82% in Iran (22). The varying prevalence 
has been attributed to the lack of standardisation on 
the determination of neuropathy. 
 Equally important is the varying characteristics 
within/amongst the study populations. In this study 
male gender was found to be significantly associated 
with neuropathy, (p = 0.01). This finding is similar 
to Mwendwa et al (14), the DCCT (21) and the San 
Louis valley diabetes study (16) Pickett (24) showed 
that females have higher nerve conduction speeds 
than males. Age was significantly associated with 
neuropathy in this study. The duration of diabetes was 
also significantly associated with the prevalence of 
neuropathy. Although studies that have demonstrated 
the strong link between poor glycaemic control and 
neuropathy have used the HBA1c as the marker for 
glycaemic control, this study was able to demonstrate 
that in our population the random blood sugar, a 
surrogate marker of metabolic control, is significantly 
associated with neuropathy (p = 0.011). The DCCT 
(21) showed a 60% reduction in the incidence of 
neuropathy among type 1 diabetic subjects in the 
group randomized to intensive glycaemic control. In 
type 2 diabetics the UKPDS (23) estimated that each 1% 
reduction in the HBA1c was associated in a 35% relative 
reduction of all micro-vascular complications.
 In this study, the prevalence of neuropathy was 
significantly increased with rise in systolic pressure 
(p = 0.034). EURODIAB (19) found that hypertension 
was associated with an odds ratio of 1.92 (p<0=0.0001) 
of incident neuropathy. The UKPDS reported 
that all microvascular outcomes were reduced by 
between 24-56% by modest BP reduction to a mean 
of 144/82mmhg (23).
 The prevalence of peripheral arterial disease 
(PAD) was 12% (26/218). The tool used was the 
Ankle Brachial Pressure Index as determined by 
the Doppler method. Nyamu et al (8), using clinical 
assessment found a prevalence of 52% in patients 
with diabetic foot ulcers. In Sudan, Elbaghir et al  (17) 
reported a prevalence of 10%. Wikbald et al (16) in 
Tanzania found a prevalence of 12%. In the UK, the 
Edinburg artery study (25) estimated the prevalence 
to be as high as 20.1%. In this study the association 
between peripheral arterial disease and age did not 
reach statistical significance although there was a 
trend towards increased occurrence with increasing 
age. Male gender was significantly associated with 
peripheral arterial disease (p=0.001). Since the 
pathogenesis involves atherosclerosis, this finding 
is in keeping with published evidence that shows a 
strong link between male gender and atherosclerotic 
manifestations. A positive association between 
peripheral arterial disease and random blood sugar 
could not be demonstrated in this study. Although 
it has been shown that advanced glycaemic end 
products may have a role in the pathogenesis of 
peripheral arterial disease in diabetics, (26) very few 
controlled studies have investigated the association 
between glycaemic control and peripheral arterial 
disease. The atherosclerosis risk in communities 
study (27) found a positive, graded, and independent 
association between A1c and PAD risk in diabetic 
adults. This association was stronger for clinical 
(symptomatic) PAD, whose manifestations may be 
related to microvascular insufficiency, than for low 
ABI. Although the mean Ankle Brachial Index was 
lower for patients with a BMI of more than 25kg/m2, 
the association between Ankle Brachial Index and 
Body Mass Index was not statistically significant 
(p=0.138). To the authors’ knowledge, no published 
well controlled studies thus far have demonstrated an 
unequivocal link between ABI and BMI. Systolic blood 
pressure was not associated with Ankle Brachial Index 
in this study (p = 0.407). The Edinburg artery study 
(25) showed that raised systolic blood pressure was 
associated with an odds ratio of 1.22 of developing 
peripheral arterial disease. 
 The study concluded that increased mean levels 
of systolic blood pressure and triglycerides may help 
to explain the higher prevalence of PAD in diabetic 
subjects. The prevalence of foot deformities in this 
study was 46%. Female gender had a significant 
statistical association with foot deformities (p = 0.012). 
Females have generally been shown to have more 
foot deformities (28,29) likely owing to the use of foot 
wear with restricted toe boxes and high heels. In our 
local setup, particularly in the rural areas, women are 
engaged in cultivation, fetching of firewood and water, 
and other activities that may result in accumulation 
of deformities particularly where they walk barefoot 
or wear inappropriate footwear. However, Abbas and 
Husam (32) in Basra has recently documented male 
gender as a risk factor for foot abnormalities in his 
study population. It is likely that foot deformities 
as a whole are more determined by gender roles as 
opposed to gender/sex per se. However, the higher 
risk deformities, i.e. claw toe, hammer toe and 
prominent metatarsals were more frequent in males 
who had significant neuropathy, and thus this may 
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explain the increased prevalence of foot ulcers in men. 
As expected, deformity was significantly associated 
with advancing age which no doubt provides a greater 
opportunity for acquisition and accumulation of 
deformities. An important finding in this study also 
shown by Nyamu et al (8) is the significant association 
between foot deformity and neuropathy. Although 
it is generally held that neuropathy, by causing 
imbalance between the toe flexors and extensors 
may ultimately lead to claw toe deformity, very few 
studies have investigated the role of neuropathy 
in the causation of foot deformity. Carine et al (31), 
in their study, concluded that although important 
relationships between motor nerve conduction deficit 
and muscle weakness were demonstrated, it was still 
not clear whether abnormal nerve function, leading 
to a decrease in muscle strength, could be responsible 
for the development of foot deformities. 
In conclusion, diabetes mellitus confers dramatic 
increase in risk of foot ulceration; however, available 
evidence suggests that this risk may be reduced 
by screening risk satisfaction and appropriate 
intervention measures (32-35). This study categorised 
33% of the participant patients at intermediate to high 
risk groups of foot ulcerations. The non modifiable 
risk factors of foot ulceration documented in this 
study were; age, duration of diabetes, deformities 
and gender. However, the modifiable risk factors 
found in the study included; poor glycaemic control, 
inadequate education (of clinicians and patients) 
on foot care, neuropathy, high systolic blood 
pressure and peripheral artery disease (albeit at low 
prevalence). It is equally important to note that then 
risk stratification, is practical in a routine care selling 
ambulatory patients with diabetes. 
 More than one third of diabetics (33%) are 
at high risk for future foot ulceration. Long term 
prospective studies should be carried out in a similar 
population locally to determine the risk of ulceration 
in the different categories since these may differ from 
studies done in the west. 
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